You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY20 is not expected to be complete until September, 2021.

  1. Novel Caenorhabditis Elegans Reagents

    SBC: ABEOME CORPORATION            Topic: N/A

    DESCRIPTION (provided by applicant): C. elegans is well established as a highly useful model organism. The 14th annual Biennial International C. elegans Conference held June 29th-July 3, 2003 elicited over 1151 abstracts published by over 2500 authors

    SBIR Phase I 2004 Department of Health and Human Services
  2. Novel Markers on Human Embryonic Stem Cells

    SBC: ABEOME CORPORATION            Topic: N/A

    DESCRIPTION(provided by applicant): Embryonic stem cells (ES) are a major focus of research, because of their experimental utility and great promise as therapeutic tissue regeneration and gene replacement agents. ES cells are rapidly growing pluripot

    SBIR Phase I 2004 Department of Health and Human Services
  3. Lymphocyte Targeting by Peptide-Drug Conjugates

    SBC: ADMUNEX THERAPEUTICS, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): The long-term objective of this work is to design bi-functional peptide-drug conjugates that specifically target leukocytes. The peptide sequences are derived from ICAM-1 and bind to LFA-1 on activated leukocytes. The

    SBIR Phase I 2004 Department of Health and Human Services
  4. SBIR Phase II: Microdisplays Based on III-Nitride Wide Band Gap Semiconductors

    SBC: III-N Technology, Inc            Topic: N/A

    The goal of this SBIR Phase II project is to bring the demonstrated Gallium Nitride (GaN) microdisplay technology to industrial maturity and to final commercialization levels. The project's goal will be accomplished by further optimizing the microdisplay device structural design and fabrication process based on the demonstrative results obtained in Phase I. Based on high-efficiency semiconductor m ...

    SBIR Phase I 2004 National Science Foundation
  5. Oviduct locus BACs for expression of bio-therapeutics

    SBC: AviGenics Inc.            Topic: N/A

    DESCRIPTION (provided by applicant): With a daily production of 400 to 2500 milligrams of protein per egg, the chicken ovomucoid and ovalbumin gene loci have the potential to synthesize large amounts of biopharmaceutical proteins in transgenic hens. This

    SBIR Phase II 2004 Department of Health and Human Services
  6. Producing humanized therapeutics in quail egg white

    SBC: AviGenics Inc.            Topic: N/A

    DESCRIPTION (provided by applicant): This project is focused on the development of a novel transgenic avian production platform that will provide human therapeutics in a rapid, cost-effective fashion. Specifically, we intend to create transgenic Japan

    SBIR Phase I 2004 Department of Health and Human Services
  7. Avian transgenesis via site-directed integration

    SBC: AviGenics Inc.            Topic: N/A

    DESCRIPTION (provided by applicant): This SBIR project describes a novel method to create transgenic poultry that will produce biopharmaceutical proteins in their eggs. Poultry, including chickens and quail, are able to produce large amounts o

    SBIR Phase I 2004 Department of Health and Human Services
  8. SBIR Phase I: A Reconfigurable Collaborative Services Framework

    SBC: Azomai Systems, Inc.            Topic: N/A

    This Small Business Innovation Research (SBIR) Phase I project is for an architectural framework for reconfigurable collaborative services as a customizable and efficient solution to computer-supported cooperative activities. The key technical areas in which this project intends to develop innovative solutions are: customizable collaboration software, robustness, and heterogeneity sup-port. Based ...

    SBIR Phase I 2004 National Science Foundation
  9. INTERACTIVE COMMUNITY HEALT COMM NTWRK

    SBC: BIOTECHNICAL COMMUNICATIONS, INC.            Topic: N/A

    N/A

    SBIR Phase I 2004 Department of Health and Human Services
  10. SBIR Phase II: Crystalline Ferroelectrics Combined with Transistor Technology

    SBC: CCVD, Inc dba MicroCoating Technologies (MCT)            Topic: N/A

    This Small Business Innovative Research Phase II project will focus on developing tunable microwave devices that utilize ferroelectric thin films for their electronic properties. Specifically, barium strontium titanate (BST) thin films are being used to develop new classes of tunable microwave devices, including phase shifters, delay lines and frequency-agile filters. ...

    SBIR Phase II 2004 National Science Foundation
US Flag An Official Website of the United States Government